ARCHIVES

In Brief: House Budget Committee Proposes 5% Cut To NIH In FY96; Steady Reductions Expected

This article is from The Cancer Letter archive.

Vol. 21 No. 12 | March 24, 1995

Download PDF Visit The Full Archive

Related Articles

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

In Brief: Hew Finally Okays New NIH Study Section For Chemical, Environmental Carcinogenesis

March 16, 1979

Surgeons Responsible For Improving Their Role, CCIRC Says

July 8, 1977

NCI Cooperative Group Clinical Trials Approved

September 24, 2010